CO5180646A1 - Procedimiento de sintesis de mezclas de oligosacaridos que comprenden unidades repetitivas de (fosfato-ribosa-ribitol)n o (ribosa-ribitol-fosfato)n - Google Patents

Procedimiento de sintesis de mezclas de oligosacaridos que comprenden unidades repetitivas de (fosfato-ribosa-ribitol)n o (ribosa-ribitol-fosfato)n

Info

Publication number
CO5180646A1
CO5180646A1 CO00064095A CO00064095A CO5180646A1 CO 5180646 A1 CO5180646 A1 CO 5180646A1 CO 00064095 A CO00064095 A CO 00064095A CO 00064095 A CO00064095 A CO 00064095A CO 5180646 A1 CO5180646 A1 CO 5180646A1
Authority
CO
Colombia
Prior art keywords
ribitol
benzyl
phosphate
disaccharide
tri
Prior art date
Application number
CO00064095A
Other languages
English (en)
Inventor
Bencomo Vicente Guillerm Verez
Rene Roy
Original Assignee
Univ La Habana
Univ De Ottawa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ La Habana, Univ De Ottawa filed Critical Univ La Habana
Publication of CO5180646A1 publication Critical patent/CO5180646A1/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/02Bacterial antigens
    • A61K39/102Pasteurellales, e.g. Actinobacillus, Pasteurella; Haemophilus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/02Acyclic radicals, not substituted by cyclic structures
    • C07H15/04Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/02Acyclic radicals, not substituted by cyclic structures
    • C07H15/04Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical
    • C07H15/08Polyoxyalkylene derivatives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/18Acyclic radicals, substituted by carbocyclic rings
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Saccharide Compounds (AREA)

Abstract

Mezclas de oligosacáridos que comprenden unidades repetitivas de fórmula (fosfato-ribosa-ribitol)n o (ribosaribitol-fosfato)n caracterizadas porque dichas mezclas son obtenidas mediante síntesis y comprenden al menos 5 compuestos de estructura A ó B siendo n un valor comprendido entre 4 y 25, y donde R1 ó R2 es un espaciador para la conjugación a un carrier, con la condición que R1= espaciador si R2=H, ó R2= espaciador si R1=H.<EMI FILE="00064095_1" ID="1" IMF=JPEG >Procedimiento para sintetizar una mezcla de oligosacáridos que comprende unidades repetitivas de fórmula (fosfato - ribosa-ribitol)n o (ribosa-ribitol-fosfato)n caracterizado porque se efectúa una reacción de policondensación de una sola etapa aplicada al derivado disacárido 19 o 23 en presencia de un promotor en un solvente básico y con un espaciador que interviene en la reacción como aceptor deteniendo el crecimiento de la cadena del oligómero.Método para la síntesis del disacárido intermediario de 2,3,4-tri-O-bencil-5-O-alil-(B-D-ribofuranosil)-D-ribitol 4 en forma pura ribosilación del 2,3,4- tri-O -bencil-5-O-alil-D-ribitol 14 con peracetato de ribofuranosa seguido de desacetilación para dar lugar al compuesto 4 que se somete a purificación por adsorción-desorción en silicagel.Método para sintetizar el disacarido intermedio 17 que comprende un procedimiento de dibencilación del disacarido 4 con óxido de dibutilestaño, yoduro de tetrabutilamonio, hidruro de sodio y cloruro de bencilo en una relación 1:0.5-2: 0.001-1, 0.5-10: 1-5, en un solvente como tolueno, benceno, tetrahidrofurano o xileno, para dar lugar al compuesto de fórmula 5, seguido de isomerización del alilo a propenilo.Disacárido 5-O-propenil-2,3,4-tri-O-bencil-1-O-(2´,5´-di-O-bencil-ß-D-ribo-furanosil)-D-ribitol 17 obtenido como intermedio en la síntesis de los derivados 19 y 23.Derivados disacarídicos 2,3,4-tri-O-bencil-1-O-(2´,5´-di-O-bencil-ß-D-ribo-furanosil)-D-ribitol-5-O-fosfonato de trietilamonio 23 y 2,3 ,4-tri-O-bencil-1-O-(2´,5´-di-O-bencil-ß-D-ribo-furanosil)-D-ribitol-3´-O-fosfonato de trietilamonio 19 obtenidos como intermedios claves en la reacción de oligomerización de las reivindicaciones de la 4 a la 9.Método para preparar los disacáridos 19 ó 23 a partir del disacárido 17, que comprende un procedimiento de fosfonilación con tricloruro de fosforo-imidazol seguido de hidrólisis del propenilo, o acetilación, hidrólisis del propenilo, fosfonilación con tricloruro de fosforo-imidazol seguido de desacetilación.
CO00064095A 1999-08-30 2000-08-28 Procedimiento de sintesis de mezclas de oligosacaridos que comprenden unidades repetitivas de (fosfato-ribosa-ribitol)n o (ribosa-ribitol-fosfato)n CO5180646A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CU1999121A CU22904A1 (es) 1999-08-30 1999-08-30 Oligosacáridos derivados de ribosa- ribitol-fosfato, métodos para prepararlos, inmunógenos que los comprenden y vacunas que comprenden dichos inmunógenos

Publications (1)

Publication Number Publication Date
CO5180646A1 true CO5180646A1 (es) 2002-07-30

Family

ID=5459405

Family Applications (1)

Application Number Title Priority Date Filing Date
CO00064095A CO5180646A1 (es) 1999-08-30 2000-08-28 Procedimiento de sintesis de mezclas de oligosacaridos que comprenden unidades repetitivas de (fosfato-ribosa-ribitol)n o (ribosa-ribitol-fosfato)n

Country Status (24)

Country Link
US (1) US6765091B1 (es)
EP (1) EP1212334B1 (es)
JP (1) JP4850377B2 (es)
KR (1) KR100818163B1 (es)
CN (1) CN1205217C (es)
AR (1) AR025435A1 (es)
AT (1) ATE308551T1 (es)
AU (1) AU780816B2 (es)
BR (1) BRPI0013686B8 (es)
CA (1) CA2382602C (es)
CO (1) CO5180646A1 (es)
CU (1) CU22904A1 (es)
CZ (1) CZ2002721A3 (es)
DE (1) DE60023722T2 (es)
DK (1) DK1212334T3 (es)
EA (1) EA005381B1 (es)
ES (1) ES2252045T3 (es)
HK (1) HK1050693A1 (es)
MX (1) MXPA02002066A (es)
NZ (1) NZ517464A (es)
SI (1) SI1212334T1 (es)
UA (1) UA75579C2 (es)
WO (1) WO2001016146A1 (es)
ZA (1) ZA200201667B (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1713508A2 (en) * 2004-01-29 2006-10-25 Biosynexus Incorporated Use of amino-oxy functional groups in the preparation of vaccine conjugates
US8647621B2 (en) 2009-07-27 2014-02-11 Fina Biosolutions, Llc Method of producing protein-carbohydrate vaccines reduced in free carbohydrate
RU2558257C2 (ru) 2009-07-31 2015-07-27 Нэшнл Рисерч Каунсл Оф Канада ВНЕШНИЙ КОРОВОЙ ЭПИТОП ЛИПОПОЛИСАХАРИДА Н. pylori
US9044517B2 (en) 2009-12-17 2015-06-02 Fina Biosolutions, Llc Activation of polysaccharides via the cyanylating agent, 1-cyano-4-pyrrolidinopyridinium tetrafluoroborate (CPPT), in the preparation of polysaccharide/protein conjugate vaccines
WO2011133191A1 (en) * 2010-04-23 2011-10-27 Serum Institute Of India, Ltd. Simple method for simultaneous removal of multiple impurities from culture supernatants to ultralow levels
JP6784841B2 (ja) 2016-07-28 2020-11-11 マックス プランク ゲゼルシャフト ツゥアー フェデルゥン デル ヴィッセンシャフテン エー フォー ヘモフィルス属インフルエンザ菌b型に対するワクチンとしての安定した加水分解耐性合成ポリリボシルリビトールホスフェート誘導体
KR20200141053A (ko) * 2018-03-23 2020-12-17 코라넥스 캐피탈 치료 도구로서의 정밀 당 접합체

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ223009A (en) * 1986-12-31 1990-06-26 Nl Rivm Of Thoven Oligosaccharides containing d-ribose d-ribitol and phosphate units mimicing haemophilus influenzae type b antigens
EP0320942A3 (en) * 1987-12-18 1989-10-04 American Cyanamid Company Novel polysaccharides novel macromolecular conjugates of the polysaccharides
US5843463A (en) * 1990-12-21 1998-12-01 Antexbiologics, Inc. Adhesin-oligosaccharide conjugate vaccine for Haemophilus influenzae

Also Published As

Publication number Publication date
CA2382602A1 (en) 2001-03-08
JP2003528032A (ja) 2003-09-24
CN1376158A (zh) 2002-10-23
AR025435A1 (es) 2002-11-27
EP1212334B1 (en) 2005-11-02
CZ2002721A3 (cs) 2002-07-17
MXPA02002066A (es) 2004-07-30
NZ517464A (en) 2004-03-26
KR100818163B1 (ko) 2008-03-31
CN1205217C (zh) 2005-06-08
JP4850377B2 (ja) 2012-01-11
BRPI0013686B1 (pt) 2016-07-26
WO2001016146A1 (es) 2001-03-08
ES2252045T3 (es) 2006-05-16
AU6817300A (en) 2001-03-26
EA005381B1 (ru) 2005-02-24
DK1212334T3 (da) 2006-03-20
CU22904A1 (es) 2004-01-23
EA200200314A1 (ru) 2002-10-31
HK1050693A1 (en) 2003-07-04
EP1212334A1 (en) 2002-06-12
DE60023722D1 (de) 2005-12-08
BRPI0013686B8 (pt) 2021-05-25
UA75579C2 (en) 2006-05-15
US6765091B1 (en) 2004-07-20
DE60023722T2 (de) 2006-07-20
ATE308551T1 (de) 2005-11-15
SI1212334T1 (sl) 2006-04-30
AU780816B2 (en) 2005-04-21
CA2382602C (en) 2010-02-16
BR0013686A (pt) 2002-08-13
KR20020068501A (ko) 2002-08-27
ZA200201667B (en) 2003-08-27

Similar Documents

Publication Publication Date Title
Bennek et al. An efficient synthesis of anhydroalditols and allylic-glycosides
Imamura et al. Extended Applications of Di‐tert‐butylsilylene‐Directed α‐Predominant Galactosylation Compatible with C2‐Participating Groups toward the Assembly of Various Glycosides
Pornsuriyasak et al. S‐Thiazolinyl (STaz) glycosides as versatile building blocks for convergent selective, chemoselective, and orthogonal oligosaccharide synthesis
CO5180646A1 (es) Procedimiento de sintesis de mezclas de oligosacaridos que comprenden unidades repetitivas de (fosfato-ribosa-ribitol)n o (ribosa-ribitol-fosfato)n
RU94042224A (ru) Способ получения олигонуклеотидов и соответствующие промежуточные соединения
KR860004921A (ko) 호모노지리마이신 글리코사이드의 제조방법
Virlouvet et al. Multi‐gram synthesis of a hyaluronic acid subunit and synthesis of fully protected oligomers
ES533607A0 (es) Un procedimiento para la preparacion de un derivado de clorodesoxisacarosa o galactato sacarosa
Sherman et al. Synthesis of Neu5Ac-and Neu5Gc-α-(2→ 6′)-lactosamine 3-aminopropyl glycosides
Vibert et al. From Polymer to Size‐Defined Oligomers: A Step Economy Process for the Efficient and Stereocontrolled Construction of Chondroitin Oligosaccharides and Biotinylated Conjugates Thereof: Part 1
Zhang et al. Chemical synthesis and biological evaluation of penta-to octa-saccharide fragments of Vi polysaccharide from Salmonella typhi
PT1133511E (pt) Novos intermediarios e processo para preparar um agente antibiotico macrolido a partir deles
Brandstetter et al. Spirohydantoins of glucofuranose: Analogues of hydantocidin
CN109912668B (zh) 岩藻糖化硫酸软骨素三糖的制备方法、中间体和用途
Haller et al. Selectively protected disaccharide building blocks for modular synthesis of heparin fragments
Perdomo et al. A glycosylation reaction: Conversion of methyl glicosides to glycosyl chlorides by boron trichloride
De Castro et al. Preparation and reactions of iodo sugars
Pozsgay et al. Synthesis of di-to penta-saccharides related to the O-specific polysaccharide of Shigella dysenteriae type 1, and their nuclear magnetic resonance study
Hara et al. Solid‐phase synthesis of fluorinated analogues of glycosyl 1‐phosphate repeating structures from Leishmania using the phosphoramidite method
Demeter et al. Short synthesis of Idraparinux by applying a 2‐O‐methyl‐4, 6‐O‐arylmethylene thioidoside as a 1, 2‐trans‐α‐selective glycosyl donor
Zou et al. Synthesis and NMR assignment of two repeating units (decasaccharide) of the type III group B Streptococcus capsular polysaccharide and its 13C-labeled and N-propionyl substituted sialic acid analogues
Shanthamurthy et al. Linear Synthesis of De novo Oligo‐Iduronic Acid
Xiong et al. Synthesis of the pentasaccharide moiety of thornasterside A
Owens et al. Facile C1 Epimerization of α-1-Sulfonamidyl-2-deoxy-2-iodo-glycopyranosides
Ercegovic et al. A study of the donor properties of sialyl phosphites having an auxiliary 3-(S)-phenylseleno group

Legal Events

Date Code Title Description
FG Application granted